Sio Capital Management »

Ocular Therapeutix shares owned by Sio Capital Management

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Sio Capital Management from 13F filings

Historical chart of Sio Capital Management investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by Sio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by Sio Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.5M 383k 9.10
2019-06-30 $263k 60k 4.41

More positions owned by Sio Capital Management

Laboratory Corporation Of America Holdings Com New (LH)
Insmed Com Par $.01 Put Option (INSM)
Cigna Corp (CI)
Globus Medical Cl A (GMED)
Madrigal Pharmaceuticals (MDGL)
GSK Sponsored Adr (GSK)
Zimmer Holdings (ZBH)
Ironwood Pharmaceuticals Com Cl A (IRWD)
Medtronic SHS (MDT)
Organon & Co Common Stock (OGN)
Tyra Biosciences (TYRA)
Embecta Corp Common Stock (EMBC)
Teleflex Incorporated (TFX)
Arcutis Biotherapeutics (ARQT)
Bridgebio Pharma (BBIO)

View all positions for Sio Capital Management

Top funds holding Ocular Therapeutix

Summer Road
VR Adviser
BlackRock
Vanguard Group
Opaleye Management
Logos Global Management
Citadel Advisors
Perceptive Advisors
Geode Capital Management
Octagon Capital Advisors
Deltec Asset Management
Franklin Resources
Dr. Jeffrey R. Jay, M.D.
Morgan Stanley
Nuveen Asset Management

View all funds holding Ocular Therapeutix